- Home
- SD vs THW Comparison
SD vs THW Comparison
Compare SD & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SD | THW |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Finance Companies |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.9M | 514.7M |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SD | THW |
|---|---|---|
| Price | $16.93 | $12.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 296.1K | 143.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.86% | N/A |
| EPS Growth | ★ 3.05 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.95 | N/A |
| Revenue Next Year | $16.82 | N/A |
| P/E Ratio | $12.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.81 | $9.80 |
| 52 Week High | $17.87 | $13.19 |
Technical Indicators
Market Signals| Indicator | SD | THW |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 46.90 |
| Support Level | $13.58 | $12.33 |
| Resistance Level | N/A | $12.83 |
| Average True Range (ATR) | 0.61 | 0.16 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 44.51 | 47.62 |
Price Performance
Historical ComparisonAbout SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.